Podcasts about Obesity

For 15 years, we have been talking with our cohost Mike D about the common sense of reading labels and not trusting the standard American diet. We recognize that so many people genuinely have no idea that soda companies or snack companies, etc., are not just selling poison, but have engaged in actions that are morally reprehensible. Coca-Cola has paid scientists to lie about their product. The sugar industry itself has paid scientist off since the 1960s to point a finger at fat. It's not just foolish, but asinine that the US pretends at every level of society to have no idea why they are overall the fattest and sickest in the world.*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKWEBSITEBuyMe-CoffeePaypal: rdgable1991@gmail.comCashApp: $rdgable EMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.

This episode covers:A study on movement vs diet, key points to understand about leaky gut, strategies for healing from the inside out, and more!Links mentioned during this episode:Leaky Gut Blog Post: https://www.thelyonsshare.org/2024/05/28/healing-your-leaky-gut-understanding-and-managing-intestinal-permeability/Movement vs Diet Study: https://www.pnas.org/doi/10.1073/pnas.2420902122Reignite Your Metabolism: https://l.bttr.to/j5wLoFree Initial Consultation: https://p.bttr.to/3a9lfYkJoin our Free Weekly Newsletter: www.thelyonsshare.org/newsletterInstagram: www.instagram.com/thelyonsshareLyons' Share Website: www.thelyonsshare.org

Dr. Hoffman continues his conversation with Dr. Aimie Apigian, author of “The Biology of Trauma: How the Body Holds Fear, Pain, and Overwhelm, and How to Heal It.”

Dr. Aimie Apigian, author of “The Biology of Trauma: How the Body Holds Fear, Pain, and Overwhelm, and How to Heal It,” details how unaddressed trauma is often the hidden cause of many preventable illnesses and is linked to eight of the ten leading causes of death. The conversation delves into the physiological responses to trauma, the mechanisms by which trauma can manifest in chronic physical ailments, and the importance of incorporating a holistic approach that includes addressing mental, somatic, and biological impacts of trauma. Dr. Apigian also shares insights from her personal journey and professional evolution, emphasizing the need for a combination of medical treatment and trauma work for optimal health.

In this episode of American Glutton, Ethan Suplee sits down with Dr. Erika Schwartz for an eye-opening conversation about health, alcohol, obesity, and the medical system. They discuss the newly established links between alcohol and cancer, the overlooked impact of obesity on chronic disease, and why quick fixes rarely work without lifestyle change.Dr. Erika shares insights from her decades of clinical experience, stressing personal responsibility, hormone health, and the dangers of blindly trusting authority. Together, they explore why awareness and ownership are the foundation of true well-being and how individuals can take back control of their health.SHOW HIGHLIGHTS00:00 – Alcohol and cancer risks03:27 – Genetics vs lifestyle04:45 – Gym closures during COVID06:02 – Culture of drinking08:08 – Obesity and healthcare blind spots12:41 – Missing obesity in medical records15:29 – Weight loss drugs and access issues17:15 – Prevention over treatment18:12 – Ethan's childhood diets20:10 – Quick fixes vs inner solutions22:22 – Medical errors and systemic failures25:40 – Hypocrisy in health movements28:26 – A patient's story of medical neglect29:50 – Women's hormones overlooked36:55 – Gender disparity in treatment39:31 – Women dropping out of society41:21 – Money, lobbying, and access42:16 – Alcohol as escape44:14 – Teaching ownership of health47:21 – Questioning authority and empowerment48:57 – Closing thoughts Hosted on Acast. See acast.com/privacy for more information.

Join 200,000 men in their prime, reading our weekly newsletter: http://muscleintelligence.com/newsletter   Unlock Your Full Muscle Building Potential With Our Complete Training Guides: https://go.muscleintelligence.com/bodypart/   Hypertrophy Execution Mastery: The most comprehensive MI40 muscle-building program EVER! https://hypertrophymastery.com/   Episode Summary: On this episode of the Muscle Intelligence Podcast, Ben Pakulski sits down with the UK's most elite transformation coaches, Gavin Attorre and Dan Smith, revealing revolutionary insights that will change how you think about fitness forever. Discover why genetics determine your personality more than you realize, how trauma lives in your body until addressed, and why AI will transform but never replace human coaching. Learn the peptide protocols changing lives, the psychology behind every successful transformation, and why stress resilience matters more than perfect programming. These coaches guarantee results by diving deeper than any trainer you've ever worked with. Top 5 Highlights: Why AI won't replace great coaches How genetics influence personality and results Stress resilience explained in simple terms The psychology of real transformation Obesity eradication within the next decade About Ben Ben Pakulski is the Chief Performance Officer to elite executives, successful entrepreneurs, and top athletes.With over 25 years of experience, he coaches high achievers to build the physical, psychological, and metabolic resilience required to lead at the highest level. As the creator of the Muscle Intelligence framework, Ben specializes in aligning biology and behavior to drive sustained peak performance. His mission is to redefine what's possible for people in their prime and push the boundaries of human potential.

Science editor Ian Sample talks through the dilemma facing more than a million people in the UK as the cost of the jabs jumps. Help support our independent journalism at theguardian.com/infocus

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-451 Overview: The obesity epidemic has fueled a demand for weight loss medications. Trials have directly compared medications—specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—with a recent study doing just that. Tune in as we explore the evidence comparing semaglutide and tirzepatide for weight loss outcomes up to 1 year. Episode resource links: Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Intern Med. 2024;184(9):1056-1064.  Moiz A, Filion KB, Toutounchi H, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials. Ann Intern Med. 2025;178(2):199-217.  Wen J, Syed B, Nadora D, et al. Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies. Endocrinol Diabetes Metab. 2025;8(3):e70045.  Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Nvidia shares hit a record high after announcing a $100 billion investment in OpenAI. Is Pfizer about to become a major player in the obesity space? Plus, how Trump's new $100K H-1B visa could impact hiring. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We live in a culture obsessed with treating symptoms, weight gain, fatigue, high blood pressure, brain fog, poor sleep, as if each were an isolated problem. But what if these struggles aren't the problem at all? What if they're just the flashing check engine lights on the dashboard of your body, pointing to a deeper issue that's been hiding in plain sight: Metabolic Disease. In this episode, Dr. JC Doornick pulls back the curtain on why nearly every chronic health crisis in America today — from obesity and Type 2 diabetes to heart disease, hypertension, and even dementia — can be traced back to metabolic dysfunction. He explains how the healthcare industry profits from keeping us stuck in a never-ending cycle of pills, injections, and quick fixes, rather than empowering us to address the root cause upstream. You'll also learn about Metabolic Synchronization — a practical, upstream approach that helps realign the body and mind through five key foundations: Proper diet & nutrition Proper movement & muscle development Proper sleep Proper education & mental detox Proper community & support This episode is a wake-up call: the lights are flashing, and the choice is yours. Will you keep patching symptoms downstream, or will you finally pop the hood and reclaim control of your health, your mind, and your future?

Welcome to the latest episode of L.I.F.T.S – your bite-sized dose of the Latest Industry Fitness Trends and Stories. In this episode, hosts Matthew Januszek and Mohammed Iqbal sit down with entrepreneur and engineer Rami Alhamad, co-founder and CEO of Alma, an AI-powered nutrition companion. From his early days building PUSH, the pioneering strength-tracking wearable later acquired by WHOOP, to his mission with Alma, Rami shares insights on persistence, startup timing, decision-making, and the future of fitness technology. Key topics covered include: How persistence and decision-making frameworks shaped Rami's entrepreneurial journey. The origins of PUSH and its role in strength-tracking innovation. Why timing is everything in startups. Rami's decision to sell PUSH to WHOOP and lessons learned. The pivot from hardware to AI-powered nutrition with Alma. Why ChatGPT is Alma's real competitor. Challenges in nutrition tracking and how AI is solving them. Insights into branding, Nike, and the importance of offline communities. Predictions for the future of fitness and consumer tech.

Send us a textHow maternal obesity epigenetically reprograms liver metabolism in offspring, predisposing them to metabolic disease.Episode Summary: Dr. Elvira Mass talks about macrophages, specialized immune cells that vary by tissue and play crucial roles beyond fighting infections, such as supporting organ function; Kupffer cells (liver macrophages) and how maternal obesity during pregnancy reprograms these cells in offspring, leading to fatty liver disease, fibrosis, and even cancer later in life, based on mouse studies showing epigenetic and metabolic shifts like increased glycolysis, with insights into developmental windows, nutritional mismatches, and broader implications for human health.About the guest: Elvira Mass, PhD, is a Professor of Developmental Immunology at the University of Bonn in Germany, where her lab focuses on the development and function of macrophages in various tissues.Discussion Points:Macrophages are diverse, tissue-specific cells that develop from embryonic precursors, performing unique tasks like providing growth factors in organs.Kupffer cells in the liver monitor blood from the gut and are exposed to maternal nutrients during fetal development.Maternal obesity (induced in mice via high-fat diets) programs offspring Kupffer cells epigenetically, leading to fatty liver in newborns and progression to diseases like cancer, even on normal diets.A "nutritional mismatch" between in utero high-fat exposure and postnatal normal diets worsens liver issues, as cells are "prepared" for excess high-fat intake but face scarcity.Key mechanism: Reprogrammed Kupffer cells overproduce apolipoproteins, driving excess lipid uptake in liver cells (hepatocytes), linked to transcription factor HIF-1α and a shift to inefficient glycolysis.Offspring from obese mothers show sex differences (males affected earlier) and persistent changes.Human parallels: Rising childhood fatty liver (once rare and tied to alcoholism) correlates with maternal obesity; studies like Dutch Hunger Winter show early gestational disruptions cause lifelong issues.Broader factors: Microbiome changes, specific fatty acids, and environmental toxins like microplastics may also reprogram macrophages; diets in studies vary beyond fat content, affecting results.Advice: Maintain consistent healthy habits pre- and during pregnancy; avoid sudden diet shifts, as developmental windows are critical for long-lived cells like Kupffer cells.Reference Paper:Study: Kupffer cell programming bySupport the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

Millions of women in perimenopause and menopause worry about osteoporosis, bone loss, and hip fractures. Weighted vests are suddenly everywhere on TikTok, Instagram, and even in doctor's offices. But do they really build bone density for women over 40 and 50, or is resistance training still the most effective way to prevent osteoporosis? In this episode, Chalene Johnson breaks down the science, the myths, and the surprising benefits of weighted vests for women navigating perimenopause and menopause. You'll hear the real research, what actually helps protect your bones, and how to safely use a vest for balance, posture, and strength as you age. With insights from orthopedic surgeon and menopause expert Dr. Vonda Wright, this episode separates fact from hype so you can age powerfully and protect your health. Watch this episode on YouTube this Sunday 

Dr. Jack Stockwell, a NUCCA Chiropractor and GAPS Practitioner in SLC, UT (866.867.5070 | ForbiddenDoctor.com | JackStockwell.com), covers the the biggest news in the health and wellness space from a holistic, naturopath perspective. First, Dr. Jack shares the latest information on the announcement out of Florida to put an end to all school vaccine mandates, what children should be eating for optimal health, and the importance of breast milk in newborns and infants. On the topic of breast milk, Dr. Jack breaks down what is happening on a chemical and hormonal level for that milk to come in for the newborn baby, how what mom eats makes it's way to her breast milk, and the connection nature has created for the connection of families from a biological stance. Additional topics include the best foods for the first year of life, why nuts and seeds should be eaten organic, and that peanuts (which are legumes) can be difficult to digest and should never be eaten unless they are absolutely organic. Moving on, the importance of fully chewing your food before swallowing, why the first meal of the day is the most important meal — but it shouldn't be had until you're actually hungry (and never skipped). Lastly, Doug joins Dr. Jack for a conversation on the deadly screwworm, a common topic discussed on Doug's American Family Farmer program Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Send us a textGrab your trainers, your dog lead, or your drink of choice and join us for some free CPD as we have another relaxed round up of recent Red Whale primary care Pearls of wisdom.  In the second of two episodes this month, Ali and Nik discuss: Obesity and weight management in pregnancy. NICE produced updated guidance on nutrition and weight management in pregnancy earlier this year. Special guest Hussain Al-Zubaidi, joins us to discuss it all…CBT for menopausal symptoms: hero, villain or just difficult to access? We take a look at the evidence for and potential benefits of CBT for menopause symptoms, and consider access issues- you can make up your own mind!Listen as soon as you can to ensure you have full access to all the free resources. And we have a  best intentions story to put a smile on your face…Obesity and weight management in pregnancyActive Pregnancy FoundationBritish Dietetic Association – pregnancy and dietSpecialist Pharmacy Service: UK Drugs in Lactation Advisory Service – safety in breastfeeding.Cognitive behaviour therapy (CBT) for menopausal symptoms Women's Health Concern (WHC 2023, Cognitive Behaviour Therapy  (CBT) for Menopausal Symptoms),NHS Inform – sleep problems and insomnia self-help guideMind - how to cope with sleep problems GP Trainee Essentials support package information, and the Red Whale Calendar for September 2025Send us your feedback podcast@redwhale.co.uk or send a voice message Sign up to receive Pearls here. Pearls are available for 3 months from publish date. After this, you can get access them plus 100s more articles when you buy a one-day online course from Red Whale OR sign up to Red Whale Unlimited. Find out more here. Follow us: X, Facebook, Instagram, LinkedInDisclaimer: We make every effort to ensure the information in this podcast is accurate and correct at the date of publication, but it is of necessity of a brief and general nature, and this should not replace your own good clinical judgement, or be regarded as a substitute for taking professional advice in appropriate circumstances. In particular, check drug doses, side-effects and interactions with the British National Formulary. Save insofar as any such liability cannot be excluded at law, we do not accept any liability for loss of any type caused by reliance on the information in this podcast....

In this episode, we give a wrap-up of late-breaking clinical science presented at the ESC Congress 2025 in Madrid. First, David Berg presents the DAPA ACT HF-TIMI 68 trial, reporting on dapagliflozin in patients hospitalized for acute heart failure, along with a meta-analysis of SGLT2 inhibitors in this setting. Next, Javed Butler highlights results of the VICTOR trial, a large phase 3 study of vericiguat in chronic heart failure with reduced ejection fraction. Then, Andre Zimerman discusses the PhysioSync-HF trial, comparing conduction system pacing with biventricular resynchronization therapy in patients with HFrEF. Finally, Kieran Docherty shares insights from a community-based study on the benefits of early initiation of disease-modifying therapy in suspected heart failure.   Additional information: Topic 1: With Gregorio Tersalvi, Mayo Clinic, Rochester, MN - USA, David Berg, Brigham and Women's Hospital, Boston - USA and Novi Yanti Sari, Siloam Hospitals Group, Jakarta - Indonesia Results paper: Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure Replay ESC Congress Hot Line: https://esc365.escardio.org/presentation/312142 Circulation. 2025 Aug 29. doi: 10.1161/CIRCULATIONAHA.125.076575.    Topic 2: With Javed Butler, Baylor Scott & White Health, Dallas - USA and Henrike Arfsten, Medical University of Vienna, Vienna - Austria Results papers: Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial Lancet. 2025 Replay ESC Congress hotline: https://esc365.escardio.org/presentation/312148 doi: 10.1016/S0140-6736(25)01665-4.  Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials Lancet. 2025 Aug 29:S0140-6736(25)01682-4. doi: 10.1016/S0140-6736(25)01682-4.   Topic 3: With Andre Zimerman, Hospital Moinhos De Vento, Porto Alegre - Brazil and Floran Sahiti, University Hospital of Wurzburg, Wurzburg - Germany Methods paper: Conduction system pacing vs biventricular resynchronization in heart failure with reduced ejection fraction and left bundle branch block: Rationale and design of the PhysioSync-HF Trial Am Heart J. 2025 Dec:290:38-45. Replay ESC Congress: https://esc365.escardio.org/session/50327 doi: 10.1016/j.ahj.2025.06.002.   Topic 3: With Kieran Docherty, University of Glasgow, Glasgow - UK and Jolie Bruno, Inserm UMR-S942, Paris - France Results paper: Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failure Eur Heart J. 2025 Aug 29:ehaf675. doi: 10.1093/eurheartj/ehaf675.    This 2025 HFA Cardio Talk podcast series is supported by Bayer AG in the form of an unrestricted financial support. The discussion has not been influenced in any way by its sponsor. 

09-17-25 - Rock Wars - New Fundraising Song To Make Kids Healthy Again And Combat ObesitySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textWhat if everything you thought you knew about weight loss was wrong? In this powerful conversation, Joey Pinz sits down with Dr. David Plourdé—scientist, author of Solving the Weight Loss Puzzle, and founder of The Plourde Method—to uncover the real science behind lasting fat loss.Dr. Plourdé shares insights from 34 years in the lab, where he studied fat cells, food addiction, and the hidden forces sabotaging our health. From uncovering insidious carbs in everyday foods to exposing the dark side of weight-loss drugs like Ozempic, his revelations will make you rethink nutrition, exercise, and the role of psychology in transformation.✨ Top 3 Highlights:

In this episode of the Intelligent Medicine podcast, Dr. Ronald Hoffman explores the concept of interoception with UK-based science journalist and author Caroline Williams. They discuss her latest book, “Inner Sense: How the New Science of Interoception Can Transform Your Health.” The conversation details the intricate relationship between the mind and body, the importance of bodily self-awareness, and how it impacts mental and physical health. Williams shares insights from her extensive research and practical strategies for enhancing interoception, such as controlled breathing exercises and body scans. They also touch on future advancements and therapeutic applications in the realm of interoception, offering listeners a comprehensive understanding of this emerging science and its potential to revolutionize healthcare.

Dr. Hoffman continues his conversation with UK-based science journalist and author Caroline Williams, author of “Inner Sense: How the New Science of Interoception Can Transform Your Health.”

09-17-25 - Rock Wars - New Fundraising Song To Make Kids Healthy Again And Combat ObesitySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Think of inflammation like a slow burn inside your body—draining your energy, stalling weight loss, and making recovery harder. The good news? You can help put out that fire with what's on your plate. I'll share 8 everyday foods that act like a fire extinguisher for inflammation. And you don't need to overhaul your diet—just small swaps that make a big difference. Resources:Need resources to help with your bariatric lifestyle? Check out our Bariatric Tools page with meal plans, recipes, GLP-1 guide, etc.AD:Visit Procarenow.com now for all of your vitamin and mineral, calcium and protein needs. Use Code: BSS10 to save $Rate, Review & Follow on Apple Podcasts:"I love Dr. Susan and Bariatric Surgery Success." If this sounds like you, would you please rate and review my podcast? I love hearing from you, and it's actually super easy for you to leave a podcast rating. Wherever you listen to the Bariatric Surgery Success podcast, go to the review section and usually click a quick star rating. If you feel like taking it one small step further, please write a review if there's a place for one. Thank you!Recipes and Videos mentioned in podcast:Golden Turmeric and Ginger Latte How to Quickly Slice an AvocadoTakeawaysInflammation can drain energy and stall weight loss.Chronic inflammation is linked to many diseases.Obesity and inflammation have a cyclical relationship.C-reactive protein is a marker for inflammation.A synergistic approach to diet is essential for anti-inflammatory effects.Fiber is a powerful anti-inflammatory component.Garlic and spices contain beneficial phytochemicals.A variety of colorful fruits and vegetables is key.Omega-3 fats from seafood help suppress inflammation.Small dietary changes can lead to significant health improvements.Chapters00:00Understanding Inflammation: The Silent Enemy04:44Eight Everyday Foods to Combat Inflammation12:59Implementing Anti-Inflammatory Foods in Your Diet

Interview with Tyson S. Barrett, PhD, and George M. Eid, MD, authors of Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists. Hosted by Jamie Coleman, MD. Related Content: Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists

Send us a textCass Health's Mary Robinson, PA-C joins us as we talk through defining obesity, our topics included:Causes of obesityTreatment optionsSignificance of diet and exercise Physiological factors & barriersObesity & mental healthRelapse avoidance strategies& more!

Sick of trying fad diets that just don't seem to work for you? Find out how to simplify your approach and succeed by learning and applying the principles of weight management.  How to make calories work for you Which proteins are better than others and when to eat protein Preserving lean muscle while losing body fat "Dirty" vs "Clean" diets Including desert and candy during a weight loss journey   APEX RX https://apexrx.net   Jesse Frank https://www.lvrgfit.com jesse.dfrank@gmail.com   Charlie Seltzer https://drseltzerlifestylemedicine.com info@drseltzerweightloss.com

Interview with Tyson S. Barrett, PhD, and George M. Eid, MD, authors of Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists. Hosted by Jamie Coleman, MD. Related Content: Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists

This episode covers:In this episode, we discuss the truth about GLP-1 weight hormones, why these medications may be overprescribed, how to naturally optimize your own hormone function, and so much more.Ashley Koff, RD, is the founder of the The Better Nutrition Program (BNP), the nutrition course director for UC Irvine's Susan Samueli Integrative Health Institute's Integrative and Functional Medicine Fellowship, and a faculty member at the Integrative and Functional Nutrition Academy (IFNA), where she teaches “An Integrative and Functional Nutrition Approach to Obesity and Weight Management.” She is also the author of the upcoming book Your Best Shot (HarperOne, Jan. 6, 2026). A practitioner for more than 25 years, Koff is leading a transformative movement in personalized nutrition, turning “better, not perfect” choices into practical, sustainable strategies that deliver real health outcomes. Through patient stories and personal experience, she shows that optimal health is not just possible — it's essential to living your fullest life. Koff has been recognized as one of CNN's Top 100 Health Makers, featured in InStyle as “Hollywood's Leading Dietitian,” and selected as Westin's global nutrition ambassador.Links mentioned during this episode:*ENROLL in Reignite Your Metabolism!! https://l.bttr.to/j5wLoAshley's GLP-1 Assessment: https://thebetternutritionprogram.com/glp1-weight-health-hormone-assessment/?utm_source=wellnessyourway&utm_medium=podcast&utm_campaign=ybsAshley's Instagram: https://www.instagram.com/ashleykoffapproved/Ashley's Book (preorder): https://amzn.to/4n8hsjTLyons' Share Instagram: www.instagram.com/thelyonsshareJoin Megan's Newsletter: www.thelyonsshare.org/newsletter

In this episode, Antonia and Andrew discuss the September 17, 2025 issue of JBJS, along with an added dose of entertainment and pop culture. Listen at the gym, on your commute, or whenever your case is on hold!   Link: JBJS website: https://jbjs.org/issue.php   Sponsor: This episode is brought to you by JBJS Clinical Classroom.   Subspecialties: Knee, Hip, Orthopaedic Essentials, Trauma, Spine, Pediatrics, Basic Science, Foot & Ankle, Rehabilitation, Education & Training, Chapters (00:00:03) - Case is On Hold(00:01:15) - JBJS CME: The 90th Anniversary(00:03:53) - Race and spinal fusion outcomes in a managed healthcare(00:08:43) - Healthcare disparities, access and healthcare segregation(00:14:40) - Clinical Equipoise in Knee Replacement Trials(00:20:48) - The issue of clinician equipoise in Osteo Surgery(00:25:52) - Obesity and postoperative knee arthroplasty outcomes(00:32:59) - The obesity issue in knee surgery(00:38:59) - Slipped capital femoral epiphysis by Navias et al(00:40:39) - Coronal and Sagittal Balance following posterior spinal fusion for adolescent id

Event Objectives:Describe the current epidemiology of pediatric obesity, including prevalence, comorbidities, and the clinical consequences of underdiagnosis.Evaluate the evidence regarding the safety and effectiveness of metabolic/bariatric surgery and pharmacotherapy (e.g., GLP-1 receptor agonists) as treatment options for adolescents with severe obesity.Identify barriers to care—including stigma, provider bias, and limited access—and propose strategies to improve referral patterns, equity, and outcomes in pediatric obesity management.Claim CME Credit Here!

Dr. Kelly Arps, Dr. Naima Maqsood, and Dr. Sahi Allam discuss modifiable risk factors and lifestyle management of atrial fibrillation with Dr. Prash Sanders. Atrial fibrillation is becoming more prevalent across the world as people are living longer with cardiovascular disease. While much of our current focus lies on the pharmacological and procedural management of atrial fibrillation, several studies have shown that targeted reduction of risk factors, such as obesity, sleep apnea, hypertension, and alcohol use, can also significantly reduce atrial fibrillation burden and symptoms. Today, we discuss the data behind lifestyle management and why it is considered the “4th pillar” of atrial fibrillation treatment. We also explore ways to incorporate prevention strategies into our general cardiology and electrophysiology clinics to better serve the growing atrial fibrillation population. Audio editing for this episode was performed by CardioNerds Intern, Julia Marques Fernandes.  CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls More people have atrial fibrillation because it is being detected earlier using wearable technology, and patients are living longer with subclinical or clinical cardiovascular disease  There are 3 components of atrial fibrillation: an electrical “trigger” + a susceptible substrate (due to age, sex, genetics) + “perpetuators” that cause the trigger to continue stimulating the substrate (lifestyle risk factors such as obesity, smoking, diabetes, etc.)  Obesity is the highest attributable risk factor for atrial fibrillation. Treating obesity often helps to treat other risk factors, such as hypertension and sleep apnea.  Counseling is patient-dependent. Most patients are unable to make major behavioral changes cold-turkey and will need to make small, incremental changes.  Dr. Sanders' tip: He tells his own patients that “atrial fibrillation is the body's response to stress.” The key to treating atrial fibrillation is to control your underlying stressors - procedures and medications are simply band-aids that do not fix the root of the problem.  Notes Notes drafted by Dr. Allam. 1. How common is atrial fibrillation?  Atrial fibrillation is the most common sustained arrhythmia. Currently, an estimated 50-60 million individuals worldwide are estimated to have atrial fibrillation, or roughly 1 in 4 individuals over the age of 45.1  The rising global prevalence of atrial fibrillation can be attributed to the aging of the population, increased rates of obesity, and greater accumulation of cardiovascular risk factors and survival with clinical cardiovascular disease.2 Atrial fibrillation is also being detected earlier through digital and wearable devices.2  Annually, we spend approximately $5,312 per adult on the management of atrial fibrillation in the United States.3  2. What is the underlying pathophysiology of atrial fibrillation? How do risk factors like sleep apnea or obesity “trigger” atrial fibrillation?  For atrial fibrillation to occur, there is an electrical “trigger”, a susceptible substrate (due to age, sex, genetics), and “perpetuators” that allow the trigger to continue stimulating the substrate.2  90% of electrical “triggers” come from the pulmonary veins  “Perpetuators” influence how the autonomic nervous system interacts with the triggers and substrate to perpetuate atrial fibrillation. Sleep apnea, obesity, and other risk factors are the “perpetuators”  Over time, as atrial fibrillation recurs, the substrate remodels to result in persistent atrial fibrillation.  3. What are some of the risk factors for atrial fibrillation and what are the possible benefits of controlling them? 

In this episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Ashley Lucas, a former professional ballerina turned PhD nutritionist and founder of PhD Weight Loss. Dr. Lucas shares her remarkable journey from struggling with under-eating and injury in the ballet world to helping over 11,000 people lose nearly 500,000 pounds by addressing the real root of weight issues: metabolic health.Together, Dr. Jenn and Dr. Ashley expose the myths of “eat less, move more,” unpack the dangers of visceral fat, and explain why true, lasting weight loss is more about hormones and mindset than willpower. They also dive into hot topics like GLP-1 weight loss drugs, protein and macro balance, over-exercise, sleep, and the misunderstood role of fat in our diets.Whether you've battled weight loss plateaus, wondered why BMI is misleading, or want to protect your long-term metabolic health, this conversation offers a science-backed roadmap for sustainable change.In This Episode, You Will Learn:How Dr. Ashley's ballet career and health collapse led her to study metabolismWhy “eat less, move more” fails most peopleThe unique dangers of visceral (belly) fat and how it drives diseaseWhy GLP-1 drugs may create more problems than they solveHow protein, fat, and carb balance impacts weight loss and metabolic healthWhy BMI is outdated—and better tools for measuring healthThe role of sleep, stress, and mindset in weight managementWhy over-exercising can sabotage fat lossPractical steps to reset metabolism and protect muscle mass

Have you heard about people buying weight loss medications from unregulated sources online? The rise of black market weight loss drugs is putting lives at risk. In this episode, I discuss the concerning trend of people purchasing Retatrutide—a medication still in clinical trials—through illegal channels. Known as the "Godzilla Jab" for its potential power, early studies suggest this drug could help people lose up to 24% of their body weight. I explain what Retatrutide is and how it compares to FDA-approved medications like Ozempic, Wegovy, Zepbound, and Mounjaro. We explore why people take dangerous risks with black market drugs, from social media hype to cost concerns and access issues. Most importantly, I share the serious health and legal risks of buying unregulated medications and provide clear guidelines for safely accessing weight loss treatments through licensed providers. Tune in to learn how to protect yourself and make informed decisions about weight loss medications the safe way.   Episode Highlights: What is Retatrutide The dangers of purchasing unregulated medications online Factors driving people to illegal sources Legal risks of buying unapproved drugs and potential health complications from unregulated substances Safe Medication Practices Understanding that medication works best when combined with healthy eating, physical activity, adequate rest, and emotional support   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Dr Leah Hechtman, one of Australia's most respected naturopathic educators, joins fx Medicine by BioCeuticals ambassador Emma Sutherland to discuss the often-overlooked stage of men's health: andropause. More than simply “low testosterone,” andropause reflects age-related changes including Leydig cell decline, metabolic changes, vascular shifts, and neurological alterations that shape male wellbeing across the lifespan. Leah outlines how andropause may present in practice, from body composition changes and hair greying to mood shifts, sleep disruption, prostate dysfunction, and reduced cognitive performance. She highlights the importance of comprehensive testing — extending beyond testosterone — to include oestrogen, progesterone, follicle-stimulating hormone (FSH), luteinising hormone (LH), insulin, leptin, insulin-like growth factor-1 (IGF-1), and DUTCH hormone analysis. These insights allow clinicians to identify early signs and develop a more complete picture of male ageing. The discussion also explores strategies that may support resilience, including optimising sleep, managing stress, and addressing metabolic health. Useful complementary medicines include nutritional considerations such as nicotinamide riboside, bioflavonoids, and zinc, as well as herbal medicines including ginkgo, grape seed extract, ashwagandha, and tribulus. The role of prostate health and testosterone therapy is also discussed. Covered in this episode: (01:01) Welcome Leah Hechtman (02:22) What is andropause? (05:16) Testosterone production and ageing (09:55) Andropause symptoms (14:28) Infertility (20:28) Autophagy, ageing and reproductive disorders (24:23) Obesity and sleep (30:53) Stress and testosterone (32:24) Prostate cancer (36:37) Erectile dysfunction (39:51) Testosterone replacement therapy (TRT) (44:37) Intermittent fasting (48:00) Testosterone receptor sensitivity (50:42) Final remarks Find today's transcript and show notes here: https://www.bioceuticals.com.au/education/podcasts/andropause-beyond-testosterone-decline Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics: www.bioceuticals.com.au/signup/ FX DISCLAIMER: The information provided on fx Medicine by BioCeuticals is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.

America didn't just accept obesity — it embraced it. From fast food to excuses to participation trophies, the culture has made being overweight “comfortable.” In this rant, I break down how America got here, why this mindset is dangerous, and what it really takes to break the cycle.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.”   He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.”   In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support.     https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and  he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections.   The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs.     Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs.   In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later   XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide).   The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems.     Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity   XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study.   “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries.   They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment.   https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX   Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year.   The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app.  https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones   XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care.  Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations.   The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe.   The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market.   The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems.   Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation.   Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options.   It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems.   “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra.   Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes.   The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations.   ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna.   The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape.   “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.”   https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m   XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results…   Well maybe that's overplaying it a little.   Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better.   Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/   XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic.   Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana.   “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp.   He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could.     “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp.   He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s.   “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp.   Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes.     Bob credits his late wife, Donna, for helping him beat the odds.   “She has been key in that I always ate on time.”   They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner.   “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp.     Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps.   “I'm not satisfied with the sensors they have today. I just don't think they're accurate.”   To many, Bob's survival is extraordinary. To him, it's luck.   “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp.     And through it all, optimism has been his compass.   “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp.   He still welds nearly every day. Not because he has to, but because it keeps him going.   “As long as I keep doing something like this, I will not be in the nursing home,” said Delp.   https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond.  Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?:   An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.   

Send us a textThe effects of protein restriction on metabolism, liver hormones, brain, and behavior.Episode Summary: Dr. Christopher Morrison talks about how animals sense and prioritize nutrients like protein, discussing defense mechanisms for essentials such as oxygen, water, sodium, and energy; the brain's role in detecting protein deprivation via signals like FGF21; trade-offs between growth, reproduction, and longevity under protein restriction; and reconciling high-protein diets for satiety and muscle maintenance with low-protein benefits for metabolic health and lifespan extension.About the guest: Christopher Morrison, PhD is a professor and researcher at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, where he has worked for over 22 years focusing on nutrition, metabolism, and chronic diseases like obesity and diabetes.Discussion Points:The body prioritizes nutrients hierarchically: oxygen and water first, then sodium, energy, and protein, with weaker defenses for carbs or fats.Animals develop specific appetites for deprived nutrients, like salt or protein, often through post-ingestive learning rather than just taste.Protein restriction (e.g., 5% vs. 20% in diets) increases food intake and energy expenditure in mice to maintain protein levels, even at the cost of extra calories.FGF21, a liver hormone, signals protein deprivation to the brain (via NTS region), driving protein-seeking behavior and metabolic changes; it's essential for low-protein responses.Protein restriction extends lifespan in lab animals by suppressing growth signals like IGF-1 and mTOR, but may impair immunity or wound healing in real-world conditions.High protein aids satiety, weight loss, and muscle building, but overconsumption may shorten lifespan; optimal intake depends on age, activity, and goals (e.g., not for pregnant or elderly).No one-size-fits-all for protein: mild restriction may benefit middle-aged sedentary people for health, while athletes need more; balance avoids excesses.Related content:M&M 106: Diet, Macronutrients, Micronutrients, Taste, Whole vs. Processed Food, Obesity & Weight Loss, Comparative Biology of Feeding Behavior | Stephen Simpson & David Raubenheimer*Not medical advice.Support the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

Sean L. Huddleston will step down as president of Martin University at the end of November. 2024 saw the second highest number of hate crimes reported in the U.S. since the FBI started collecting data. A new group aimed at encouraging independent candidates in Indiana will launch a statewide ad campaign. The Indiana Youth Institute is highlighting the rise of obesity in central Indiana youth. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

What if a drug could help chemotherapy patients continue treatment without painful side effects? Hoth Therapeutics (NASDAQ: HOTH) is making that possible by developing innovative treatments that address unmet medical needs and help patients maintain their therapy safely.In this interview, CEO Robb Knie discusses HT001, the company's lead drug currently in Phase 2 trials for chemotherapy-induced rash, and HTKIT, which shows promise in cancer treatment. He also shares how the company is advancing programs for Alzheimer's and obesity, including an obesity drug licensed from the U.S. Department of Veterans Affairs.With a diversified pipeline, a patient-focused approach, and strategic use of AI to de-risk and accelerate development, Hoth Therapeutics is positioning itself as a biotech company to watch.Learn more about Hoth Therapeutics: https://hoththerapeutics.comWatch the full YouTube interview here: https://youtu.be/AYQa3g6dVLA?si=w_zDH0TaSxP3m6JiAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

Join experts in obesity, Robert Kushner, MD, Michael Knight, MD, and Amanda Velazquez, MD, as they discuss impactful communication for patients with obesity. Bob Kushner, MD  Amanda Velazquez, MB, DABOM Michael Knight, MD, MSHP, FACP, DABOM

Elan and Kiki are the Co-founders at Sourmilk, a modern Greek-style yogurt made for your gut. WHAT WE GO OVER:Co-Founders' origin story at StanfordCease & Desist, Benny -> Sourmilk The bet on yogurt, reverse engineering the product to truly support gut healthThe Sourmilk "Drug Deal Model" - 5k units in 7 weeks! Who the founders look up toThe dairy company they think gets acquired nextCONNECT WITH US:Connect with Vasa on LinkedinConnect with Elan and Kiki on LinkedInPerfy's websiteCPGSPN by Growthbuster, a CPG newsletter with a sports themeCheck out Sourmilk SPONSOR:Food Chained is a Perfy podcast brought to you by Growthbuster. Growthbuster is a team of creatives and strategists that help food & beverage brands grow. Check out Growthbuster's newsletter, CPGSPN here. 

Episode Highlights With CourtneyWhy this conversation is so important right now, and why 74% of adults are obese or overweight and over 50% of kids areNon-alcoholic fatty liver disease didn't even exist decades ago, and it's now rampantHer own journey into health and wellness The biggest offenders and contributors to why we're seeing this drastic rise60% of Americans' diets are coming from ultra-processed foodsThe real problem with food dyes and the sneaky places they're hidingLinks between food dyes and behavioral issues, cancer, and why most countries have banned themWhy glyphosate is such a big problemMisleading food labeling and the illusion of choice The real deal on vegetable oils and how these are impacting our food supply Look at what has changed so much in the last 50 years in our food supply- our genes don't change that fast20% of Americans' calories come from seed oilsThe role of big agriculture and government subsidiesUnderstanding GMOs and how they impact usWe're only as healthy as our soil is Count chemicals, not calories- why we are overfed and under nourished Two great films on this: Common Ground and Kiss the Ground Resources We MentionHer InstagramRealfoodology - WebsiteRealfoodology - PodcastCommon Ground DocumentaryKiss the Ground DocumentaryMy Health Forward - Regenerative Farms

Send us a textShannon Davis, RD is a returning guest on our show! Be sure to check out her first appearance on episode 857 of Boundless Body Radio! Shannon Davis, RD is a Registered Dietitian with 19 years of expertise in metabolic health, specializing in the prevention and reversal of chronic diseases through evidence-based, root-cause approaches. Her diverse clinical background includes organ transplants, bariatrics, sports nutrition, nephrology, and pharmaceutical sales.As the founder of her own virtual preventative and metabolic health practice, Shannon empowers clients to overcome insulin resistance and achieve lasting health by moving beyond traditional calorie-counting models. She integrates strategies such as low-carb, ketogenic, and carnivore diets, intermittent fasting, nutraceutical support, and exercise to promote optimal metabolic function.Shannon serves on the founding board of the American Diabetes Society and is a coach for Dr. Ben Bikman's Insulin IQ program. Additionally, she is a practicing dietitian at OWNA Health, working alongside renowned endocrinologist Dr. Mariela Glandt.A passionate advocate for metabolic health, Shannon is dedicated to educating others on the critical role of insulin resistance in chronic disease. Shannon also enjoys CrossFit, weightlifting, running, horseback riding, golf, and exploring the outdoors.Find Shannon at-FB- Functional Foodie RxIG- @sldavis6580LK- Sharon Davis, RDUnicity Take Control Americas 2025 Eventhttps://linktr.ee/shannondavisFind Boundless Body at- myboundlessbody.com Book a session with us here!

Episode 25:37 Here's 4 Ways To Lower Your A1C Level Naturally  More than 100 million Americans have elevated blood sugar levels… and don't even know it! Another 50 million have elevated levels and DO know it. That's not good! It's not good because elevated blood sugar levels lead to deadly sicknesses and diseases. Disease such as Obesity, Type 2 Diabetes, Heart Disease, Cancer, Alzheimer's and Dementia. So, how do you know if blood sugar levels are elevated? It's easy! Simply have your doctor order a blood test known as an “A1C Test.” If your A1C score is above 5.4 it's considered to be elevated (high).  It also places you at high risk for developing any of the diseases mentioned above. Fortunately, elevated levels of blood sugar… high A1C levels… can be reduced naturally, without drugs. On this episode I discuss four specific tactics for doing just that. Four lifestyle habits that you can begin to implement immediately that will help reduce your blood sugar levels and decrease your risk of developing a chronic disease.  Be sure to give this episode a good listen and, as always, share it with a friend. Thanks! ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the “Symptom Survey” and you will automatically added to our email list. ———————- Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)  

               * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

Dr. Hoffman continues his conversation with Dr. Martin Picard, Chair in Energy and Health, and Professor of Behavioral Medicine at Columbia University, as well as head of the Mitochondrial PsychoBiology Lab.

Dr. Martin Picard, Chair in Energy and Health, and Professor of Behavioral Medicine at Columbia University, as well as head of the Mitochondrial PsychoBiology Lab, delves into the complex functions of mitochondria beyond their well-known role as cellular powerhouses. Dr. Picard shares his journey from biology to psychobiology, exploring the intersection between mitochondrial function, mental health, and overall well-being. He discusses how mitochondria not only produce energy but also influence behaviors, stress responses, and healing processes. The conversation highlights recent findings on mitochondrial roles in psychiatric disorders, the impact of diet and lifestyle on mitochondrial health, and the potential of ketogenic diets in treating psychiatric conditions. Dr. Picard also previews his upcoming book on understanding life and health from an energetic perspective. The episode emphasizes a holistic approach to health, integrating mind-body practices and lifestyle changes to support mitochondrial function.

Meal replacements are an excellent tool for weight management. But they aren't the same as protein shakes. Medical weight-loss dietitian Julia Axelbaum joins me to clear up the confusion, define the difference (they are not interchangeable), and map out exactly when to use each—on their own or alongside evidence-based tools like GLP-1s. You'll walk away with a 3-step label checklist you can teach patients, practical strategies to curb evening cravings, and a step-by-step plan for transitioning patients back to real food without the weight regain.  Join the Obesity Medicine Nutrition Course! Use POD15 for 15% off!Get 40% off Cozy Earth Sheets here. Use code EXAM at checkout.Resources:Episode 93: Contaminated Protein SupplementsFREEBIE: How to Choose a Protein SupplementConnect with Julia at https://www.formhealth.co/Got a nutrition question? Send me a voicemail. Any Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week. Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer.

My friend Bill Streetman, who I have known for many years, wrote a book about his bariatric journey. The book is called Simple... not Easy!: Escaping the Prison of Obesity. Bill has been super active in the bariatric community, inspiring hundreds of people who have also been dealing with obesity. During our conversation, Bill and I talk about how weight loss is about so much more than pounds lost, but is a path to living life fully! The Weight Loss Winformation Podcast gives you essential psychological information to help you lose weight and more importantly, to help keep you at a healthy weight for your body! No matter how you are working to lose weight and no matter how much weight you want to lose, Weight Loss Winformation will keep you moving in a positive direction.Resources:BariAfterare: www.bariaftercare.comConnie Stapleton PhD website: www.conniestapletonphd.comBariAftercare website: https://www.conniestapletonphd.com/bariaftercareBariAftercare Facebook page (for members only): https://www.facebook.com/groups/BariAftercareKevin Stephens: Your Bariatric Buddy   https://www.facebook.com/groups/yourbariatricbuddy/peopleInstagram: @cale101 (Caleshia Haynes)Instagram: @therealbariboss (Tabitha Johnson)Instagram @drsusanmitchell (Dr. Susan Mitchell)Instagram: @lauraleepreston (Laura Preston)ProCare Vitamins (10% off with code ConnieStapleton)Rob DiMedio: https://www.busybariatrics.com/Dr. Joan Brugman: drjbrugman@outlook.comDr. Susan Mitchell:https://www.facebook.com/DrSusanMitchellhttps://www.facebook.com/bariatricsurgerystrategiesBill Streetman: https://www.facebook.com/bill.streetmanSimple... not Easy!: Escaping the Prison of Obesity

EPISODE 145 | Trumpspiracies: What a Tangled Web Ever since Donald Trump first decided to run for the highest office in the United States, he has promoted an astonishing number of conspiracy theories. It's almost as if a New York real estate baron famous for lying to clients, not paying his bills and exploiting loopholes for his own benefit had learned, somewhere along the way, that “truth” is a slippery subject. And because he's not a very deep thinker, he has, like many people, confused truth with facts. Like what we do? Then buy us a beer or three via our page on Buy Me a Coffee.  Review us here or on IMDb. And seriously, subscribe, will ya?  SECTIONS 02:25 - Liar, Liar - 9/11 nonsense, open season on Muslims 08:50 - Would I Lie to You? - Boogeyman Obama, Birtherism  19:02 - Suspicious Minds - The Clintons, Biden, robot clones, Canada, assassinations, self delusion as super power 29:22 - Liar, Liar, Burn in Hell - Science, medicine, the Great Replacement, crime stats, Britain First, tweets and retweets 38:31 - Dance Little Liar - Haitians eating pets, conspiracy theorists in his administration 46;40 - Liar (It Takes One to Know One) - 2016 Russian election interference, Spygate, #Obamagate, Trump's impeachments Music by Fanette Ronjat More Info 58 Donald Trump Conspiracy Theories (And Counting!): The Definitive Trump Conspiracy Guide (from 2016) President Obama's Long History of Insulting Donald Trump The birth of the Obama 'birther' conspiracy ‘Birtherism,' Trump and anti-Black racism: Conspiracy theorists twist evidence to maintain status quo Trump's history of launching "birther" conspiracy theories against rivals Trump promotes 'totally baseless' birther conspiracy theory against Nikki Haley Trump claims media 'dishonest' over crowd photos Comparison: Donald Trump and Barack Obama's inauguration crowds Trump's crowd-size obsession to be tested at inauguration after 2017 controversy The surprising reason why the Park Service won't count folks at Trump's inauguration 'It eats him alive inside': Trump's latest attack shows endless obsession with Obama 12 false claims Trump has made about Obama since last month (from 2020) Trump's obsession with Obama took an ominous turn this week Twitter use by Donald Trump A farewell to @realDonaldTrump, gone after 57,000 tweets FBI 2019 crime statistics Trump Says He's Going To Check If ‘Somebody Stole' Fort Knox $400 Billion Gold Supply. What We Know. No Evidence Haitian Immigrants Are Eating Ducks, Geese or Pets in Springfield, Ohio ‘They're eating the pets:' Trump, Vance earn PolitiFact's Lie of the Year for claims about Haitians Altogether fitting and proper? Trump repeatedly compares himself to Abraham Lincoln Donald Trump: Height, Weight, Obesity, and Documentation Seriously, What Is “Obamagate”? | The Daily Social Distancing Show (video) How Trump's Obsession With a Conspiracy Theory Led to the Impeachment Crisis Trump impeachment trial: Conspiracy theories and fidget spinners How the Senate Could Bar Donald Trump from Running for President in 2024 Follow us on social: Facebook X (Twitter) Other Podcasts by Derek DeWitt DIGITAL SIGNAGE DONE RIGHT - Winner of a Gold Quill Award, Gold MarCom Award, AVA Digital Award Gold, Silver Davey Award, and Communicator Award of Excellence, and on numerous top 10 podcast lists.  PRAGUE TIMES - A city is more than just a location - it's a kaleidoscope of history, places, people and trends. This podcast looks at Prague, in the center of Europe, from a number of perspectives, including what it is now, what is has been and where it's going. It's Prague THEN, Prague NOW, Prague LATER 

Researchers at the Liggins Institute at Auckland University believe a capsule of healthy gut bugs could change the future of obesity treatment. 

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)Ever wonder why the same weight loss plan can work wonders for one person but barely move the needle for another?Or why some people respond really well to medications like Wegovy, while others struggle with side effects or see minimal results? That's exactly what precision obesity medicine aims to answer—and today, we're diving into it with one of the world's leading experts.We're joined by Dr. Andres Acosta, a true pioneer in obesity medicine and the creator of the obesity phenotypes concept. He's board-certified in internal medicine, gastroenterology, hepatology, obesity medicine, and nutrition. At the Mayo Clinic, he co-directs the Nutrition and Obesity Research Program and leads the Precision Medicine for Obesity program, focusing on matching the right treatment to the right patient with fewer side effects.Dr. Acosta's research is supported by the National Institutes of Health, with more than 145 peer-reviewed papers in top journals. His work has been featured in The New York Times, TIME, CNN, and NPR, and he's earned “40 Under 40” recognition and co-founded Genomic Sciences—just a glimpse of his many accomplishments.If you've ever felt frustrated by trial-and-error weight loss or wondered if there's a more scientific way to find what actually works for you, you're going to want to hear what Dr. Acosta shares in this episode.Connect with Dr. Acosta:Mayo Clinic: mayu.eduPhenomix Sciences: WebsiteConnect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com